Substrate
science

Researchers Develop New Tools to Detect Parkinson’s Disease Earlier

Scientists are testing devices that analyze handwriting, tremors, and bodily fluids to identify Parkinson’s disease before symptoms become obvious. The approaches aim to address the shortage of specialists and support earlier intervention.

Science News
1 source·May 21, 5:45 PM(8 days ago)·1m read
|
Researchers Develop New Tools to Detect Parkinson’s Disease EarlierScience News
Audio version
Tap play to generate a narrated version.

Neurologist David Standaert at the University of Alabama at Birmingham says he can often identify Parkinson’s disease within minutes by observing tremors, reduced arm swing, softer voice, and limited facial expression. Standaert states that more than 1 million people in the United States have the disease and that fewer than 1,000 movement disorder specialists are available to diagnose them.

He notes that the number of cases is rising as the population ages.

Standaert explains that Parkinson’s varies widely between patients, with differences in symptom onset, severity, and progression rate. He says no two patients present identically. Diagnosis currently relies on movement-related symptoms and, in uncertain cases, a DaTscan imaging test that costs about $3,000 and takes several hours.

Chen at the University of California, Los Angeles, has developed a soft ball that measures hand tremors through magnetoelastic signals when squeezed. Chen’s team reported in February that the device detects pressures below one kilopascal. Chen has also created a pen that records tremors during writing and an intelligent keyboard that tracks typing pressure patterns.

He says daily use of the keyboard could flag changes that indicate early disease. Stanford movement disorder specialist Kathleen Poston says dozens of drugs targeting the underlying causes of Parkinson’s are now in clinical trials. She states that these treatments differ from current symptom-management options.

Key Facts

1 million
people in the United States living with Parkinson’s
Fewer than 1,000
movement disorder specialists in the United States
$3,000
cost of a DaTscan imaging test

Story Timeline

2 events
  1. February

    Jun Chen’s team reported a soft ball device that detects hand tremors below one kilopascal.

    1 sourceScience News
  2. Recent years

    Dozens of drugs targeting root causes of Parkinson’s entered clinical trials.

    1 sourceScience News

Potential Impact

  1. 01

    Earlier detection could allow patients to enter clinical trials for disease-modifying drugs.

  2. 02

    New devices may reduce reliance on specialist evaluations for initial screening.

Transparency Panel

Sources cross-referenced1
Confidence score75%
Synthesized bySubstrate AI
Word count228 words
PublishedMay 21, 2026, 5:45 PM
Bias signals removed2 across 1 outlet
Signal Breakdown
Amplifying 1Speculative 1

Related Stories

WHO Director Visits Congo as Ebola Outbreak SpreadsNpr
science4 hrs ago

WHO Director Visits Congo as Ebola Outbreak Spreads

The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.

Npr
France 24
2 sources
FDA Panel Recommends XFG Variant for Fall Covid Shotsmedpagetoday.com
science2 hrs agoDeveloping

FDA Panel Recommends XFG Variant for Fall Covid Shots

Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.

Stat
1 source
Benzinga Publishes Article on Biotech Stocks During Pandemic Recoveryfinance.yahoo.com
science6 hrs agoDeveloping

Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery

Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…

Benzinga
1 source